Three independent pharmacokinetic studies were conducted to assess potential drug interactions between argatroban administered concomitantly with commonly prescribed drugs in the hospital setting that ...
"In the DIG trial, published in 1997, digoxin had a neutral effect on the primary endpoint of mortality, but a 28% reduction in heart failure hospitalizations (a secondary endpoint) was observed.
Digoxin, a cardiac glycoside derived from the foxglove plant, has been a mainstay of treatment in systolic heart failure and in rate control for atrial fibrillation. By inhibiting the cardiac ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results